178 related articles for article (PubMed ID: 10357838)
1. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
[TBL] [Abstract][Full Text] [Related]
2. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
3. Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo.
Lambert G; Amar MJ; Martin P; Fruchart-Najib J; Föger B; Shamburek RD; Brewer HB; Santamarina-Fojo S
J Lipid Res; 2000 May; 41(5):667-72. PubMed ID: 10787427
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase.
Mowri HO; Patsch JR; Gotto AM; Patsch W
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):755-62. PubMed ID: 8640403
[TBL] [Abstract][Full Text] [Related]
6. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
7. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
[TBL] [Abstract][Full Text] [Related]
8. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
Hedrick CC; Castellani LW; Wong H; Lusis AJ
J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.
Dugi KA; Amar MJ; Haudenschild CC; Shamburek RD; Bensadoun A; Hoyt RF; Fruchart-Najib J; Madj Z; Brewer HB; Santamarina-Fojo S
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):793-800. PubMed ID: 10712405
[TBL] [Abstract][Full Text] [Related]
10. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton EA; Eisenberg S; Breslow JL
Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
[TBL] [Abstract][Full Text] [Related]
11. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
12. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
13. Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.
Mowri HO; Patsch W; Smith LC; Gotto AM; Patsch JR
J Lipid Res; 1992 Sep; 33(9):1269-79. PubMed ID: 1402396
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF
Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733
[TBL] [Abstract][Full Text] [Related]
15. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.
Rashid S; Watanabe T; Sakaue T; Lewis GF
Clin Biochem; 2003 Sep; 36(6):421-9. PubMed ID: 12951168
[TBL] [Abstract][Full Text] [Related]
18. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype.
Mahley RW; Pépin J; Palaoğlu KE; Malloy MJ; Kane JP; Bersot TP
J Lipid Res; 2000 Aug; 41(8):1290-301. PubMed ID: 10946017
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
Ohta T; Ikeda Y; Hattori S; Matsuda I
Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
[TBL] [Abstract][Full Text] [Related]
20. Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II.
Broedl UC; Jin W; Fuki IV; Millar JS; Rader DJ
J Lipid Res; 2006 Oct; 47(10):2191-7. PubMed ID: 16877778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
